Search

everythinglearnresearchcommunity

for

Search:↓

The CLASI is useful but needs revision to accurately assess all cutaneous lupus erythematosus subtypes.

Black patients with discoid lupus erythematosus have more severe skin damage and higher chances of dyspigmentation, scalp, and ear involvement.

CLASI is a valid tool for assessing skin activity and damage in lupus patients.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Higher EULAR/ACR scores in SLE patients predict more organ damage.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

Patients with cutaneous lupus erythematosus have a severely impaired quality of life, especially emotionally.

Patients with cutaneous lupus are most concerned about self-consciousness, physical symptoms, and disease progression.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

New tools and criteria have been developed to better assess and treat pediatric lupus.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Skin problems are common in Lupus patients and can indicate the disease's severity, requiring specific treatments and lifestyle changes.

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Absence of skin rash and low complement C3 levels increase the risk of lupus nephritis.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Pollution exposure speeds up hair damage.

Hydroxychloroquine may help delay skin damage in lupus patients.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Researchers created a rat model to study skin damage caused by radiation, which could help develop new treatments.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Caragana korshinskii seed oil effectively treats fungal skin infections.

A new AI model diagnoses hair and scalp disorders with 92% accuracy, better than previous models.

Ranitidine and finasteride lower TMAO levels, reducing heart and kidney damage by changing gut bacteria.